BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8358347)

  • 1. In vivo instability of reduction-mediated 99mTc-labeled monoclonal antibody.
    Sakahara H; Saga T; Endo K; Hattori N; Hosono M; Kobayashi H; Shirato M; Yamamuro T; Toyama S; Arano Y
    Nucl Med Biol; 1993 Jul; 20(5):617-23. PubMed ID: 8358347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bis(hydroxamamide)-based bifunctional chelating agent for 99mTc labeling of polypeptides.
    Xu LC; Nakayama M; Harada K; Kuniyasu A; Nakayama H; Tomiguchi S; Kojima A; Takahashi M; Ono M; Arano Y; Saji H; Yao Z; Sakahara H; Konishi J; Imagawa Y
    Bioconjug Chem; 1999; 10(1):9-17. PubMed ID: 9893958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of internally labeled monoclonal antibodies as a gold standard: comparison of biodistribution of 75Se-, 111In-, and 125I-labeled monoclonal antibodies in osteogenic sarcoma xenografts in nude mice.
    Koizumi M; Endo K; Watanabe Y; Saga T; Sakahara H; Konishi J; Yamamuro T; Toyama S
    Cancer Res; 1989 Apr; 49(7):1752-7. PubMed ID: 2924318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between in vitro binding activity and in vivo tumor accumulation of radiolabeled monoclonal antibodies.
    Sakahara H; Endo K; Koizumi M; Nakashima T; Kunimatsu M; Watanabe Y; Kawamura Y; Nakamura T; Tanaka H; Kotoura Y
    J Nucl Med; 1988 Feb; 29(2):235-40. PubMed ID: 3162255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the radiochemical design of antibodies with a metabolizable linkage for target-selective radioactivity delivery.
    Arano Y; Wakisaka K; Akizawa H; Ono M; Kawai K; Nakayama M; Sakahara H; Konishi J; Saji H
    Bioconjug Chem; 1998; 9(4):497-506. PubMed ID: 9667952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of human osteogenic sarcoma xenografts in nude mice by a monoclonal antibody labeled with radioiodine and indium-111.
    Sakahara H; Endo K; Nakashima T; Koizumi M; Kunimatsu M; Kawamura Y; Ohta H; Nakamura T; Tanaka H; Kotoura Y
    J Nucl Med; 1987 Mar; 28(3):342-8. PubMed ID: 3469333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody-dendrimer conjugates enable radiolabeling of antibody with markedly high specific activity with minimal loss of immunoreactivity.
    Kobayashi H; Sato N; Saga T; Nakamoto Y; Ishimori T; Toyama S; Togashi K; Konishi J; Brechbiel MW
    Eur J Nucl Med; 2000 Sep; 27(9):1334-9. PubMed ID: 11007515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of radiochemical design of antibodies using an ester bond as the metabolizable linkage: evaluation of maleimidoethyl 3-(tri-n-butylstannyl)hippurate as a radioiodination reagent of antibodies for diagnostic and therapeutic applications.
    Arano Y; Wakisaka K; Ohmono Y; Uezono T; Akizawa H; Nakayama M; Sakahara H; Tanaka C; Konishi J; Yokoyama A
    Bioconjug Chem; 1996; 7(6):628-37. PubMed ID: 8950481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved clearance of radiolabeled biotinylated monoclonal antibody following the infusion of avidin as a "chase" without decreased accumulation in the target tumor.
    Kobayashi H; Sakahara H; Hosono M; Yao ZS; Toyama S; Endo K; Konishi J
    J Nucl Med; 1994 Oct; 35(10):1677-84. PubMed ID: 7931671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo radiolocalization of antiosteogenic sarcoma monoclonal antibodies in osteogenic sarcoma xenografts.
    Nakamura T; Sakahara H; Hosoi S; Yamamuro T; Higashi S; Mikawa H; Endo K; Toyama S
    Cancer Res; 1984 May; 44(5):2078-83. PubMed ID: 6585270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeating the avidin "chase" markedly improved the biodistribution of radiolabelled biotinylated antibodies and promoted the excretion of additional background radioactivity.
    Kobayashi H; Sakahara H; Endo K; Yao ZS; Toyama S; Konishi J
    Eur J Cancer; 1995 Sep; 31A(10):1689-96. PubMed ID: 7488426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct technetium-99m labeling of three anticancer monoclonal antibodies: stability, pharmacokinetics and imaging.
    Gooden CS; Snook DE; Maraveyas A; Rowlinson-Busza G; Peters AM; Epenetos AA
    J Nucl Med; 1995 May; 36(5):842-9. PubMed ID: 7738662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A newly designed radioimmunoconjugate releasing a hippurate-like radiometal chelate for enhanced target/non-target radioactivity.
    Arano Y; Matsushima H; Tagawa M; Inoue T; Koizumi M; Hosono M; Sakahara H; Endo K; Konishi J; Yokoyama A
    Nucl Med Biol; 1994 Jan; 21(1):63-9. PubMed ID: 9234265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A human/mouse chimeric monoclonal antibody against CA125 for radioimmunoimaging of ovarian cancer.
    Kobayashi H; Sakahara H; Saga T; Hosono M; Shirato M; Kanda H; Ishibashi K; Watanabe T; Endo K; Ishiwata I
    Cancer Immunol Immunother; 1993 Aug; 37(3):143-9. PubMed ID: 7687520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of a metabolizable ester bond in radioimmunoconjugates.
    Arano Y; Wakisaka K; Mukai T; Uezono T; Motonari H; Akizawa H; Kairiyama C; Ohmomo Y; Tanaka C; Ishiyama M; Sakahara H; Konishi J; Yokoyama A
    Nucl Med Biol; 1996 Feb; 23(2):129-36. PubMed ID: 8868284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretargeting of carcinoembryonic antigen-expressing tumors with a biologically produced bispecific anticarcinoembryonic antigen x anti-indium-labeled diethylenetriaminepentaacetic acid antibody.
    van Schaijk FG; Oosterwijk E; Soede AC; Broekema M; Frielink C; McBride WJ; Goldenberg DM; Corstens FH; Boerman OC
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7130s-7136s. PubMed ID: 16203812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB/c nude mice.
    Clarke K; Lee FT; Brechbiel MW; Smyth FE; Old LJ; Scott AM
    Cancer Res; 2000 Sep; 60(17):4804-11. PubMed ID: 10987290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of 111In- and 125I-labeled monoclonal antibody 17-1A in mice bearing xenografts of human pancreatic carcinoma HuP-T4.
    Maeda M; Shoji M; Kawagoshi T; Futatsuya R; Honda T; Brady LW
    Cancer; 1994 Feb; 73(3 Suppl):800-7. PubMed ID: 8306263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoconjugate stability in vivo measured by label release from 125I or 99mTc-antibody coated cells kept in intraperitoneal diffusion chambers in mice.
    Fjeld J; Brorson B; Martinussen GK; Benestad H; Nustad K
    Acta Oncol; 1993; 32(7-8):873-6. PubMed ID: 8305239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of sarcoma xenografts in nude mice with indium-111-labeled monoclonal antibodies.
    Chao TC; Blend MJ; Lopes AD; Atcher RW; Das Gupta TK; Greager JA
    J Surg Res; 1993 Jul; 55(1):38-43. PubMed ID: 8412080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.